Michael F. Holick, MD, PhD

Professor, Medicine

Michael Holick
85 E. Newton St Fuller Building


Dr. Holick has made numerous contributions to the field of the biochemistry, physiology, metabolism, and photobiology of vitamin D for human nutrition. Dr. Holick has established global recommendations advising sunlight exposure as an integral source of vitamin D. He has helped increase awareness in the pediatric and medical communities regarding vitamin D deficiency pandemic, and its role in causing not only metabolic bone disease, and osteoporosis in adults, but increasing risk of children and adults developing preeclampsia, common deadly cancers, schizophrenia, infectious diseases including TB and influenza, autoimmune diseases including type 1 diabetes and multiple sclerosis, type 2 diabetes, stroke and heart disease.

Dr. Holick is a Diplomate of the American Board of Internal Medicine, a Fellow of the American College of Nutrition, and a member of the American Association of Physicians. He is the recipient of numerous awards and honors, including the General Clinical Research Centers Program Award for Excellence in Clinical Research from NIH, American College of Nutrition’s Communication Media Award, Best Docs in America, the Linus Pauling Functional Medicine Award from the Institute for Functional Medicine and the Linus Pauling Prize for Human Nutrition. Dr. Holick serves on a number of national committees and editorial boards and has organized and/or co-chaired several international symposia. He served as the chair for the Endocrine Society’s Practice Guidelines on Vitamin D. He has authored more than 400 peer-reviewed publications, and written more than 200 review articles, as well as numerous book chapters. He has acted as editor and/or co-editor on 13 books, and has written The UV Advantage in 2004 and The Vitamin D Solution in 2010 and helped develop the dminder.info app.

Other Positions

  • Professor, Physiology & Biophysics, Boston University School of Medicine
  • Director, General Clinical Research Unit, Boston University Medical Campus
  • Director, Bone Health Care Clinic, Boston Medical Center
  • Director of the Vitamin D, Skin and Bone Research Laboratory, Endocrinology, Diabetes, Nutrition & Weight Management, Medicine, Boston University School of Medicine
  • Mentor for Graduate Medical Students, Boston University School of Medicine, Graduate Medical Sciences
  • Active Staff Privileges, Endocrinology, Diabetes, Nutrition & Weight Management, Medicine, Boston Medical Center


  • University of Wisconsin-Madison, MD
  • University of Wisconsin-Madison, PhD
  • University of Wisconsin-Madison, MS
  • Seton Hall University, BS


  • Published on 8/1/2019

    Charoenngam N, Rujirachun P, Holick MF, Ungprasert P. Oral vitamin D3 supplementation increases serum fibroblast growth factor 23 concentration in vitamin D-deficient patients: a systematic review and meta-analysis. Osteoporos Int. 2019 Aug 01. PMID: 31372708.

    Read at: PubMed
  • Published on 7/8/2019

    Charoenngam N, Hossein-Nezhad A, Hanley DA, Holick MF. Misconception about the cause of vitamin D toxicity. CMAJ. 2019 Jul 08; 191(27):E769. PMID: 31285383.

    Read at: PubMed
  • Published on 5/29/2019

    Pludowski P, Grant WB, Konstantynowicz J, Holick MF. Editorial: Classic and Pleiotropic Actions of Vitamin D. Front Endocrinol (Lausanne). 2019; 10:341. PMID: 31191460.

    Read at: PubMed
  • Published on 4/22/2019

    Sulibhavi A, Rohlfing ML, Jalisi SM, McAneny DB, Doherty GM, Holick MF, Noordzij JP. Vitamin D deficiency and its relationship to cancer stage in patients who underwent thyroidectomy for papillary thyroid carcinoma. Am J Otolaryngol. 2019 Jul - Aug; 40(4):536-541. PMID: 31036419.

    Read at: PubMed
  • Published on 4/20/2019

    Chaiprasongsuk A, Janjetovic Z, Kim TK, Jarrett SG, D'Orazio JA, Holick MF, Tang EKY, Tuckey RC, Panich U, Li W, Slominski AT. Protective effects of novel derivatives of vitamin D3 and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol. 2019 Jun; 24:101206. PMID: 31039479.

    Read at: PubMed
  • Published on 3/9/2019

    Kleine CE, Obi Y, Streja E, Hsiung JT, Park C, Holick MF, Kalantar-Zadeh K. Seasonal variation of serum 25-hydroxyvitamin D and parameters of bone and mineral disorder in dialysis patients. Bone. 2019 Jul; 124:158-165. PMID: 30858148.

    Read at: PubMed
  • Published on 3/7/2019

    Buckley AJ, Barakat MT, Holick MF, Lessan N. Parameters of Bone and Cardiovascular Health Related to 25-Hydroxyvitamin D Status in Emirati Nationals attending Primary Care and Diabetes services: a retrospective cohort study. Sci Rep. 2019 Mar 07; 9(1):3835. PMID: 30846793.

    Read at: PubMed
  • Published on 3/5/2019

    Cocate PG, Kac G, Heitmann BL, Nadanovsky P, da Veiga Soares Carvalho MC, Benaim C, Schlüssel MM, de Castro MBT, Alves-Santos NH, Baptista AF, Holick MF, Mokhtar RR, Bomfim AR, Adegboye ARA. Calcium and vitamin D supplementation and/or periodontal therapy in the treatment of periodontitis among Brazilian pregnant women: protocol of a feasibility randomised controlled trial (the IMPROVE trial). Pilot Feasibility Stud. 2019; 5:38. PMID: 30873290.

    Read at: PubMed
  • Published on 2/1/2019

    Cannell J, Holick MF. Response to Culotta et al. regarding Letter to the Editor about "Multiple unexplained fractures in infants and child physical abuse" by Paige Culotta MD, Amy Mehollin-Ray MD, and Marcella Donaruma-Kwoh MD. J Steroid Biochem Mol Biol. 2019 02; 186:228-231. PMID: 30665621.

    Read at: PubMed
  • Published on 1/1/2019

    Holick MF. A Call to Action: Pregnant Women In-Deed Require Vitamin D Supplementation for Better Health Outcomes. J Clin Endocrinol Metab. 2019 Jan 01; 104(1):13-15. PMID: 30239761.

    Read at: PubMed

View 558 more publications: View full profile at BUMC

View all profiles